MannKind | MNKD - Market Capitalization


MannKind reported $1.63B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 3.49B 853M Sep/2025
Dynavax Technologies USD 1.16B 26M Sep/2025
Eli Lilly USD 722.15B 16.64B Sep/2025
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Insmed USD 30.44B 11.35B Sep/2025
MacroGenics USD 114M 8M Feb/2026
MannKind USD 1.65B 511M Sep/2025
Merck USD 293.38B 83.74B Feb/2026
Novo Nordisk DKK 246.32B 60.06B Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Sanofi EUR 100.88B 4.46B Dec/2025
Xencor USD 837M 278M Sep/2025